Pacifica Partners Inc. - LINEAGE CELL THERAPEUTICS IN ownership

Back to all holdings Add to watchlist

LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 115 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Pacifica Partners Inc. ownership history of LINEAGE CELL THERAPEUTICS IN
ValueSharesWeighting
Q4 2023$2,926
-23.7%
2,9260.0%0.00%
-50.0%
Q3 2023$3,833
-3.0%
2,9260.0%0.00%0.0%
Q2 2023$3,950
-2.5%
2,9260.0%0.00%0.0%
Q1 2023$4,050
+31.7%
2,9260.0%0.00%0.0%
Q4 2022$3,075
-23.1%
2,9260.0%0.00%
-33.3%
Q3 2022$4,0000.0%2,9260.0%0.00%0.0%
Q2 2022$4,0000.0%2,9260.0%0.00%0.0%
Q1 2022$4,000
-33.3%
2,9260.0%0.00%
-25.0%
Q4 2021$6,000
-25.0%
2,9260.0%0.00%
-33.3%
Q3 2021$8,0000.0%2,9260.0%0.01%0.0%
Q2 2021$8,000
+14.3%
2,9260.0%0.01%0.0%
Q1 2021$7,000
+40.0%
2,9260.0%0.01%
+20.0%
Q4 2020$5,000
+66.7%
2,9260.0%0.01%
+66.7%
Q3 2020$3,000
+50.0%
2,9260.0%0.00%
+50.0%
Q2 2020$2,0000.0%2,9260.0%0.00%0.0%
Q1 2020$2,000
-33.3%
2,9260.0%0.00%
-33.3%
Q4 2019$3,000–2,926–0.00%–
 Download
Other shareholders
LINEAGE CELL THERAPEUTICS IN shareholders Q2 2021
NameSharesValueWeighting ↓
Defender Capital, LLC. 5,036,720$14,354,0004.77%
BROADWOOD CAPITAL INC 34,005,379$96,915,0004.33%
Prescott General Partners LLC 1,851,851$5,278,0000.17%
Raffles Associates 43,590$124,0000.10%
Laidlaw Wealth Management LLC 123,730$353,0000.09%
DCF Advisers, LLC 74,500$212,0000.08%
Beirne Wealth Consulting Services, LLC 45,000$128,0000.07%
Strategic Wealth Investment Group, LLC 64,232$183,0000.06%
Paradigm, Strategies in Wealth Management, LLC 19,775$56,0000.05%
Fort Sheridan Advisors LLC 47,931$137,0000.05%
View complete list of LINEAGE CELL THERAPEUTICS IN shareholders